Chemours Company (the) · NYSE:CC
Chemours Company (the) — Q1 2025 Earnings Presentation
30 slides from Chemours Company (the)'s earnings presentation, May 7, 2025
Slide 1: First Quarter 2025 Earnings Presentation
First Quarter 2025 Earnings Presentation May 6, 2025
Slide 2: Safe Harbor Statement and Other Matters
Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp
Slide 3: First Quarter 2025 Highlights
First Quarter 2025 Highlights Continued strong execution of Chemours’ Pathway to Thrive three-year corporate strategy Generated $1.4B in Net Sales and $166M in Adjusted EBITDA Achieved 40% YoY Net Sales growth for Opteon Refrigerants in TSS, reflecting continued strong adoption Signed liquid cooling
Slide 4: First Quarter 2025 Financial Summary
First Quarter 2025 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 1Q25 1Q24 5 Y-o-Y ∆ 4Q24 5 Q-o-Q ∆ Net Sales $1,368 $1,362 $6 $1,359 $9 Net (Loss) / Income 1 ($4) $54 ($58) ($10) $6 Adj. Net Income 2 $19 $47 ($28) $10 $9 EPS 3 ($0.03) $0.36 ($0.39) ($0.07) $0.
Slide 5: Adjusted EBITDA Bridge: 1Q25 versus 1Q24
Adjusted EBITDA Bridge: 1Q25 versus 1Q24 ($ in millions) ($53) ($8) ($1) $15 $22 $191 $166 1Q24 5 Price Volume Cost/Other Currency Portfolio 1Q25 Price Impacts: ($53) million due to lower pricing primarily in TSS due to lower Freon pricing and TT based on regional pricing dynamics Volume Impacts: $2
Slide 6: Quarterly Segment Summary
Quarterly Segment Summary ($ in millions unless otherwise noted) Net Sales 5 TSS TT APM $494 $454 $466 $632 $591 $597 $393 $303 $294 1Q23 1Q24 1Q25 1Q23 1Q24 1Q25 1Q23 1Q24 1Q25 Adjusted EBITDA and Margin 5 (%) TSS TT APM $30 $32 $185 $150 $141 $70 $69 $50 $84 1Q23 1Q24 1Q25 1Q23 1Q24 1Q25 1Q23 1Q24
Slide 7: Liquidity Position as of March 31, 2025
Liquidity Position as of March 31, 2025 ($ in millions unless otherwise noted) Total Liquidity 9 $1.1B Gross Debt $4.1B Net Debt 10 $3.7B TTM Net Leverage 11 5.0x $763 $50 Restricted ($112) $514 ($84) ($37) ($16) $50 Restricted $713 $464 Unrestricted Unrestricted 6 7 8 6 4Q24 Cash Balance Operating
Slide 8: Strategic Progress: Pathway to Thrive
Strategic Progress: Pathway to Thrive 8
Slide 9: Our Corporate Strategy: Pathway to Thrive
Our Corporate Strategy: “Pathway to Thrive” Pillars for Success PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long Term ❑ Manufacturing excellence as ❑ Investing smartly in selected ❑ Holistic portfolio analysis ❑ Measurable progress on a basis for s
Slide 10: Our Corporate Strategy: Significant Progress Achieved to Date
Our Corporate Strategy: “Pathway to Thrive” Significant Progress Achieved to Date PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long Term ✓ Notable progress against the ✓ 40% YoY growth in Opteon ✓ Progressed APM European asset ✓ Drove advocacy for t
Slide 11: Enabling Growth: Liquid Cooling Market Adoption
Enabling Growth: Liquid Cooling Market Adoption Advanced in Next Gen Chips will Drive the Need for Liquid Cooling Tech Over Time ➢ Data center chip technology advancements driven by artificial intelligence (AI) is requiring increased power consumption, heat emittance, and server rack density12 ➢ New
Slide 12: Enabling Growth: Innovation Through Two-Phase Liquid Cooling Fluids
Enabling Growth: Innovation Through Two-Phase Liquid Cooling Fluids Two-Phase Direct to Chip Two-Phase Immersion Cooling Key technology to bridge from single phase direct-to-chip to two-phase immersion cooling Preferred solution to provide lowest total cost of ownership for high-performance computin
Slide 13: Liquid Cooling Addressable Market
Enabling Growth: Data Center Liquid Cooling | Total Addressable Fluid Market Long-Term Market Expansion Driven by Demand for Artificial Intelligence Infrastructure ➢ Liquid cooling solutions will be critical to enable the use of next generation chips and optimize the $3 Billion total cost of ownersh
Slide 14: Strengthening the Long-Term: Resolving Legacy Liabilities
Strengthening the Long-Term: Resolving Legacy Liabilities Significant Progress Since Spin on Key Legacy-Related Matters January 2021: June 2023: 2017: December 2024: Memorandum of Understanding with U.S. Public Water Prioritization of Resolving First Ohio MDL Corteva, EID, DuPont and System Class Ac
Slide 15: Q2 and Full Year Guidance
in Q2 and Full Year Guidance 15
Slide 16: Second Quarter 2025 Guidance
Second Quarter 2025 Guidance Sequential Business Outlook: ($ in millions) Consolidated 2Q25 Net Sales and Adjusted EBITDA Outlook o Net Sales: Expected to increase in the low-to-mid teens (%) sequentially o Adjusted EBITDA: Expected to increase between 40% to 45% sequentially Net Sales o Corporate
Slide 17: Full Year 2025 Outlook
Full Year 2025 Outlook16 Key Business Factors and Assumptions FY25 Adjusted EBITDA range refined to primarily account for a dynamic Adjusted TT market landscape with historical volatility EBITDA $825M - $950M High end of Adjusted EBITDA range anticipates a more favorable demand environment for T
Slide 18: Appendix
Appendix
Slide 19: TSS Segment Net Sales and Adjusted EBITDA
TSS Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) % of total Net Sales $454 $466 FP&O FP&O 18% ($32) $44 19% Freon Freon Refrigerants Refrigerants 21% 38% Opteon Opteon Refrigerants Refrigerants $150 $141 60% 44% 1Q24 Price/Currency Volume 1Q25 1Q24 Price/Currenc
Slide 20: TT Segment Net Sales and Adjusted EBITDA
TT Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) $591 $597 ($30) $36 $69 $50 1Q24 Price/Currency Volume 1Q25 1Q24 Price/Currency Volume Cost/Other 1Q25 Net Sales: The increase was primarily driven by a 6% increase in volume concentrated in western markets where f
Slide 21: APM Segment Net Sales and Adjusted EBITDA
APM Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) % of total Net Sales $303 $294 Performance ($7) ($2) Performance Solutions Solutions 37% 39% Advanced Advanced Materials Materials 63% 61% $32 $30 1Q24 Price/Currency Volume 1Q25 1Q24 Price/Currency Volume Cost/Ot
Slide 22: Segment Net Sales
Segment Net Sales (Unaudited)5 ($ in millions) 2022 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Net sales by product group and segment OpteonTM refrigerants $ 143 $ 182 $ 150 $ 122 $ 195 $ 200 $ 170 $ 145 $ 200 $ 227 $ 205 $ 178 $ 279 FreonTM refrigerants 197 241 177 135 185 226 170 141 17
Slide 23: Segment Net Sales by Region
Segment Net Sales by Region (Unaudited)5 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Net sales by geographic region North America: Thermal & Specialized Solutions $ 292 $ 319 $ 258 $ 207 $ 271 $ 308 $ 256 $ 194 $ 233 Titanium Technologies 262 277 273 242 246 274 270 236 267 Advanced Performance Materi
Slide 24: Segment Net Sales and Adjusted EBITDA
Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) Three Months Ended Three Months Ended March 31, December 31, 2025 2024 2024 SEGMENT NET SALES Thermal & Specialized Solutions $ 466 $ 454 $ 390 Titanium Technologies 597 591 632 Advanced Performance Materials 294 303 324 Other Non-Re
Slide 25: GAAP Net (Loss) Income to Adjusted Net Income and Adjusted EBITDA Reconciliation (1/2)
GAAP Net (Loss) Income Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio5 (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended March 31, Decemb
Slide 26: GAAP Net (Loss) Income to Adjusted Net Income and Adjusted EBITDA Reconciliation (2/2)
GAAP Net (Loss) Income Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio5 (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended March 31, Decemb
Slide 27: GAAP Operating Cash Flow to Free Cash Flow Reconciliation
GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and Free Cash Flow Conversion Reconciliation ($ in millions) Three Months Ended March 31, December 31, 2025 2024 2024 Cash flows (used for) provided by operating activities $ (112) $ (290) $ 138 Less: Purchases of property, plant, an
Slide 28: Revisions to Previously Presented Segment Net Sales and Adjusted EBITDA
Revisions to Previously Presented Segment Net Sales, Segment Adjusted EBITDA, Adjusted Net Income and Consolidated Adjusted EBITDA5 Three Months Ended March 31, 2024 Three Months Ended June 30, 2024 Three Months Ended September 30, 2024 As Reported Adjustments As Revised As Reported Adjustments As R
Slide 29: 2025 Estimated GAAP Net Income to Estimated Adjusted EBITDA
2025 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted Net Income, Estimated Adjusted EBITDA(*) (In millions except per share amounts) (Estimated) Year Ending December 31, 2025 Low High Net income attributable to Chemours $ 168 $ 263 Restructuring, transaction, and other costs
Slide 30: ® 2025 CHEMOURS. ALL RIGHT RESERVED
® 2025 CHEMOURS. ALL RIGHT RESERVED
Chemours Company (The) — Q1 2025 Earnings Presentation on 6ix